Rubradirin treatment of methicillin-resistant staph

Details Rubradirin treatment of methicillin-resistant staph Rubradirin treatment of methicillin-resistant staph

1987-01-23

1988-06-07

Schain, Howard E.

Drug, bio-affecting and body treating compositions

Fermentate of unknown chemical structure

Having a known elemental analysis

424404, 424414, 435128, 435886, A61K 3574

Patent

active

047495685

ABSTRACT:
It has been discovered that rubradirin can be used to treat rubradirin-sensitive, methicillin-resistant staphylococcal infections.

REFERENCES:
patent: 3335057 (1967-08-01), Johnson et al.
patent: 4137410 (1979-01-01), Hoeksema

Affiliated with

Also associated with

Rating

Rubradirin treatment of methicillin-resistant staph does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Rubradirin treatment of methicillin-resistant staph, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rubradirin treatment of methicillin-resistant staph will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-843989